STAT+: Pharmalittle: FDA advisers vote overwhelmingly against ALS treatment; weight-loss drugs scrutinized over reports of suicidal thoughts
STAT -

A FDA advisory panel voted overwhelmingly against a polarizing potential treatment for ALS, concluding that supporting data were inadequate.

Related Articles

Latest in News

More from STAT | Pharma Pharmalot pharmalittle STAT+